Certified by Founder Lodge
GLOX Therapeutics Ltd.
United Kingdom - Glasgow
START UP
1 Disclosed Funding Rounds $5,362,000
0 Participating Investments
-
Founded date
2023
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Glox Therapeutics Ltd. is developing novel precision antibiotics based on protein bacteriocins, which have potent narrow-spectrum activity to target Gram-negative Antimicrobial Resistant (AMR
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 15 ,2023 | Unknown | $5,362,000 |
Boehringer Ingelheim
Scottish Enterprise
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Furientis | $5,000,000 | (May 19, 2026)
Arkeus | $18,000,000 | (May 19, 2026)
Shyld AI | $13,400,000 | (May 19, 2026)
Cimento AI | $3,000,000 | (May 19, 2026)
Cosmico | $12,000,000 | (May 19, 2026)
